A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (retrospective)

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2023000063

Enrollment

Unknown

Registered

2023-12-04

Start date

2023-12-05

Completion date

Unknown

Last updated

2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Exposure group:Blood Activating Formula

Non-exposure group:Non-Blood-activating Formula

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Compliance with Western medical diagnostic criteria for coronary heart disease; (2) Age = 18 years old; (3) Completed treatment with complete medical records of initial and follow-up consultations.

Exclusion criteria

Exclusion criteria: (1) Patients with severe primary diseases such as combined hepatic and renal insufficiency, hematopoietic system abnormalities, and neurological diseases; (2) Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Coronary Heart Disease Chinese Medicine Symptoms Score Scale;	—

Secondary

Measure	Time frame
Angina Point Scale;	—

Countries

China

Contacts

Public ContactFang Lu

Xiyuan Hospital, China Academy of Chinese Medical Sciences

deerfang@126.com13651132246

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026